Correction: Review and analysis of clinical trials of selective RET inhibitors for the treatment of thyroid cancer - Poll - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Correction: Reevaluation of Clinical Trials Involving Selective RET Inhibitors for Thyroid Cancer Treatment

  • By

  • Yulu Zhou

  • Junjie Cao

  • Siqi Zhang

  • Mingjun Sun

  • Yaqi Zhang

  • Songzhe Li

  • Zining Luo

  • Pengyu Wang

  • Jiebin Xie

  • August 14, 2026

Share

Original Source(s)

Correction: Review and analysis of clinical trials of selective RET inhibitors for the treatment of thyroid cancer

  • by Yulu Zhou, Junjie Cao, Siqi Zhang, Mingjun Sun, Yaqi Zhang, Songzhe Li, Zining Luo, Pengyu Wang, Jiebin Xie

  • August 14, 2026

Related Content

Correction: Lipid profile-based prognostic nomograms for obstructive colorectal cancer: multi-cohort development and validation

Expanding the donor pool in secondary AML: a step forward, with caveats

Correction: Surgical treatment and prognosis in patients with intestinal metastases originated from advanced epithelial ovarian cancer